SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-055096
Filing Date
2024-05-08
Accepted
2024-05-08 08:30:44
Documents
61
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q apvo-20240331.htm   iXBRL 10-Q 1261528
2 EX-31.1 apvo-ex31_1.htm EX-31.1 14989
3 EX-31.2 apvo-ex31_2.htm EX-31.2 15206
4 EX-32.1 apvo-ex32_1.htm EX-32.1 9121
5 EX-32.2 apvo-ex32_2.htm EX-32.2 9716
  Complete submission text file 0000950170-24-055096.txt   5895909

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT apvo-20240331.xsd EX-101.SCH 1145546
65 EXTRACTED XBRL INSTANCE DOCUMENT apvo-20240331_htm.xml XML 679715
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37746 | Film No.: 24924386
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)